Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left Ventricular Thrombus.

Peter J. Stokman1, Charn S. Nandra, Richard W. Asinger

  • 1Cardiology Division 865A, Hennepin County Medical Center, 701 Park Avenue South, Minneapolis, MN 55415, USA. asing001@tc.umn.edu

Current Treatment Options in Cardiovascular Medicine
|November 7, 2001
PubMed
Summary
This summary is machine-generated.

Left ventricular thrombus (LVT) is a complication of myocardial infarction (MI) and dilated cardiomyopathy (DCM). Anticoagulation can prevent LVT embolism and stroke but carries bleeding risks, necessitating careful risk-benefit assessment.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Thrombosis Research

Background:

  • Left ventricular thrombus (LVT) is a significant complication in patients experiencing acute anterior myocardial infarction (MI) and those with dilated cardiomyopathy (DCM).
  • The primary clinical concern with LVT is its propensity for embolization, leading to potentially devastating embolic events.
  • While reperfusion therapy has reduced LVT incidence post-MI, stroke remains a critical complication, particularly following anterior MI, often linked to LVT embolization.

Purpose of the Study:

  • To review the incidence, risks, and current management strategies for left ventricular thrombus (LVT) in acute myocardial infarction (MI) and dilated cardiomyopathy (DCM).
  • To evaluate the efficacy and risks associated with anticoagulation therapy for LVT prevention and treatment.
  • To discuss alternative diagnostic and therapeutic strategies for managing LVT and preventing cardioembolic stroke.

Main Methods:

  • Review of existing literature on left ventricular thrombus (LVT) in acute myocardial infarction (MI) and dilated cardiomyopathy (DCM).
  • Analysis of the role of therapeutic anticoagulation in reducing LVT formation and embolic events.
  • Discussion of risk stratification and diagnostic approaches, including echocardiography, for LVT management.

Main Results:

  • Therapeutic anticoagulation during acute MI reduces LVT incidence and may decrease cardioembolic strokes, particularly in anterior MI with apical dysfunction.
  • Long-term anticoagulation is associated with reduced recurrent infarction and ischemic stroke but increases hemorrhagic risk, especially when combined with antiplatelet agents.
  • Echocardiographic evaluation to guide anticoagulation in anterior MI is a potential strategy, though unproven. Anticoagulation is generally indicated if LVT is detected in MI or DCM.

Conclusions:

  • Left ventricular thrombus (LVT) management requires balancing the benefits of anticoagulation against bleeding risks, particularly in acute myocardial infarction (MI) and dilated cardiomyopathy (DCM).
  • While anticoagulation can prevent embolic events, its prophylactic use remains controversial due to potential harms.
  • Further clinical studies are needed to establish optimal strategies, such as using echocardiography to guide targeted anticoagulation for LVT.